BSE filing, BSE: 541338. Summary written from the filing by ALFA Finder's alert engine.
U H Zaveri Ltd: key numbers
- Share price
- ₹6.35
- Market cap
- ₹19.42 Cr
- Revenue (annual)
- ₹43.45 Cr
- Net profit (annual)
- ₹0.05 Cr
- P/E (TTM)
- 327.5×Sector 49.5×
- Promoter holding
- 39.27%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from U H Zaveri Ltd
All →U H Zaveri Board Meeting Date
U. H. Zaveri intimates a board meeting on 30 October 2026 to consider standalone unaudited results for the quarter and half year ended 30 September 2026. The trading window has been closed since 1 October 2026.
U H Zaveri Other Announcement
U. H. Zaveri Limited appointed M/s. P H Shah and Co. as Statutory Auditor and M/s. SS Lunkad and Associates as Secretarial Auditor for five years.
U H Zaveri Annual General Meeting
U. H. Zaveri Ltd concluded its 9th Annual General Meeting on September 28, 2026, where shareholders adopted annual financial statements and approved new auditor appointments.
U H Zaveri Annual General Meeting
U. H. Zaveri Limited has issued a notice for its 9th Annual General Meeting scheduled to be held on September 28, 2026.
U H Zaveri Annual Report
U. H. Zaveri Limited has submitted its Integrated Annual Report and Notice of the 9th Annual General Meeting for the financial year 2025-26.
U H Zaveri Other Announcement
U. H. Zaveri Limited has appointed M/s SS Lunkad and Associates as the Secretarial Auditor for a five-year term starting from the financial year 2026-27.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.